Mimi Fenton

Chief Executive Officer

Dr. Mimi Fenton, CEO of Cedar Research and Aspen Insights, is an experienced Life Sciences executive with 20+ years of experience in Global Pharmaceuticals (Sanofi), Pharmaceutical Services (Syneos Health), Retail/Pharmacy (Walmart) and Academia (Columbia University, Rutgers University). Mimi has extensive experience developing innovative evidence generation strategies to unlock powerful drug and device value propositions across clinical and commercial applications. Mimi is a business builder with demonstrated success architecting corporate strategy, building teams & processes, driving revenue & flywheel value, and creating commercial, technological and academic partnerships. She empowers teams to bridge the gap between science, innovation, and go-to-market with the intelligent application of data and technology. Mimi has also led her previous teams’ efforts to drive profitable growth, accelerate drug development, enable access, and improve patient lives. Mimi has a Ph.D. in Epidemiology from Columbia University, an M.P.H. from Brown University, and a B.A. from the University of Pennsylvania. She is a thought leader in her field and sits on the Board of Directors for Arkansas Children’s Hospital and the Board of Advisors for Carna Health and Uncommon Cures.